ReviewPharmacoEconomics2019

Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Joanna Picot et al.PubMed ↗Publisher ↗

No numbers read from the abstract.